[Form 4] Iridex Corp Insider Trading Activity

Rhea-AI Filing Summary

Iridex Corp (IRIX) Form 4: Romeo R. Dizon, identified as the Chief Financial Officer, reported three transactions on 09/04/2025. The filing shows acquisitions of 404, 96, and 625 common shares at prices of $1.32, $1.345, and $1.39 respectively. After those transactions the filing lists beneficial ownership totals of 54,029, 54,125, and 54,750 shares. The form was signed by an attorney-in-fact on 09/05/2025.

Positive

• Insider purchases disclosed: The CFO reported acquisitions totaling 1,125 shares on 09/04/2025, increasing beneficial ownership to 54,750 shares.
• Timely reporting and signature: The Form 4 includes an attorney-in-fact signature dated 09/05/2025, indicating the filing was executed.

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO made three small purchases on 09/04/2025, modestly increasing reported beneficial ownership.

The reported transactions consist of three acquisitions totaling 1,125 common shares executed at incremental prices of $1.32, $1.345, and $1.39. Reported post-transaction beneficial ownership figures rise from 54,029 to 54,750 shares. These are routine insider purchases disclosed on Form 4 and, standing alone, do not provide performance metrics or change in company fundamentals in the filing.

Corporate Governance Expert

TL;DR: Disclosed insider purchases are properly reported and signed by an attorney-in-fact; filing shows compliance with Section 16 reporting.

The Form 4 lists the reporter as CFO and includes an attorney-in-fact signature dated 09/05/2025. All three transactions are dated 09/04/2025 and specify share counts and prices. The filing contains no amendments, derivative transactions, or explanatory footnotes beyond the signature block.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2025		P		404	A	$1.32	54,029	D
Common Stock	09/04/2025		P		96	A	$1.345	54,125	D
Common Stock	09/04/2025		P		625	A	$1.39	54,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo Dizon	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did IRIX insider Romeo R. Dizon report on Form 4?

The Form 4 reports three acquisitions on 09/04/2025 of 404, 96, and 625 common shares at prices of $1.32, $1.345, and $1.39 respectively.

What was Romeo Dizon's reported beneficial ownership after these transactions?

The filing lists beneficial ownership totals of 54,029, 54,125, and 54,750 shares following each reported transaction.

What is Romeo Dizon's role at IRIDEX Corp as stated on the Form 4?

The Form 4 identifies Romeo R. Dizon as the company's Chief Financial Officer.

When was the Form 4 signed and by whom?

The Form 4 was signed by Nilo De Castro, Attorney-in-fact for Romeo Dizon on 09/05/2025.

Does the filing report any derivative transactions for the reporting person?

No. Table II for derivative securities contains no reported transactions or amounts in the filing.